These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3129277)

  • 1. [Results of thyrostatic therapy of hyperthyroidism in patients with Basedow's disease and disseminated autonomy].
    Meng W; Meng S; Hampel R; Ventz M; Männchen E; Weber W; Streckenbach B
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):337-40. PubMed ID: 3129277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Follow-up studies of patients with negative TRH test and normal thyroid hormone levels].
    Döge H; Hübner O; Kempe K; Riedel A; Ortweiler W
    Z Gesamte Inn Med; 1993 Aug; 48(8):398-400. PubMed ID: 8379222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prognostic value of thyroid stimulating antibodies after antithyroid drug treatment of Graves' disease].
    Li J; Gao H; Xu L
    Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):218-20, 254-5. PubMed ID: 7922762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective studies of the long-term course of various forms of hyperthyroidism with special reference to prognostic aspects].
    Keil I; Nahrendorf T; Hüller M; Schambach H
    Z Gesamte Inn Med; 1989 Nov; 44(22):677-81. PubMed ID: 2483282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is the recurrence rate for Basedow's disease treated with thyrostatic agents. Answers from a prospective study].
    Schleusener H; Peters H; Fischer C; Holle R; Bogner U; Reinwein D; Benker G
    Schweiz Med Wochenschr; 1990 May; 120(21):769-71. PubMed ID: 2349460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid hormone dynamics during the thyrostatic treatment of Basedow's disease].
    Vŭrbanov V; Zakharieva B; Manolov D; Zhelev N
    Vutr Boles; 1990; 29(1):68-73. PubMed ID: 1697716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proceedings: T3 suppression test and TSH and prolactin reactions to TRH in patient with Basedow's disease under treatment with thyroid antagonists].
    Ikeda H; Imai Y; Uchimura H; Yamaji T; Matsuzaki S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):108. PubMed ID: 4141667
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of therapy duration and low and highly dosed thiamazole treatment in Basedow's-Graves' disease.
    Meng W; Meng S; Männchen E; Hampel R; Kirsch G; Dannenberg J; Krabbe S
    Exp Clin Endocrinol; 1991 May; 97(2-3):257-60. PubMed ID: 1915642
    [No Abstract]   [Full Text] [Related]  

  • 17. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
    Hoeschel M; Heinze HG
    Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concept of endocrine ophthalmopathies].
    Heberting HJ; Schwarzmann E
    Z Gesamte Inn Med; 1974 Sep; 29(17):712-5. PubMed ID: 4141190
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy.
    Sugimoto K; Sasaki M; Isobe Y; Tamayose K; Hieda M; Oshimi K
    Eur J Haematol; 2005 Jan; 74(1):73-4. PubMed ID: 15613111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.